Colorectal Cancer Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators), By Application (Radiotherapy, Chemotherapy), Regional Insights and Forecast From 2026 To 2035